These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 33740231)

  • 1. HPV Vaccine Experiences and Preferences Among Young Adult Cancer Survivors and Caregivers of Childhood Cancer Survivors.
    Waters AR; Mann K; Vaca Lopez PL; Kepka D; Wu YP; Kirchhoff AC
    J Cancer Educ; 2022 Oct; 37(5):1519-1524. PubMed ID: 33740231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPV vaccination knowledge, intentions, and practices among caregivers of childhood cancer survivors.
    Kirchhoff AC; Mann K; Warner EL; Kaddas HK; Fair D; Fluchel M; Knackstedt ED; Kepka D
    Hum Vaccin Immunother; 2019; 15(7-8):1767-1775. PubMed ID: 31116634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suboptimal uptake of human papillomavirus (HPV) vaccine in survivors of childhood and adolescent and young adult (AYA) cancer.
    Castellino SM; Allen KE; Pleasant K; Keyes G; Poehling KA; Tooze JA
    J Cancer Surviv; 2019 Oct; 13(5):730-738. PubMed ID: 31342304
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implementation barriers and considerations for recommending and administering the human papillomavirus (HPV) vaccination in oncology settings.
    Waters AR; Weir C; Kramer HS; van Thiel Berghuijs KM; Wu Y; Kepka D; Kirchhoff AC
    J Cancer Surviv; 2024 Oct; 18(5):1481-1491. PubMed ID: 37147553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of a provider-focused intervention for maximizing human papillomavirus (HPV) vaccine uptake in young cancer survivors receiving follow-up care in pediatric oncology practices: protocol for a cluster-randomized trial of the HPV PROTECT intervention.
    Landier W; Bhatia S; Richman JS; Campos Gonzalez PD; Cherven B; Chollette V; Aye J; Castellino SM; Gramatges MM; Lindemulder S; Russell TB; Turcotte LM; Colditz GA; Gilkey MB; Klosky JL
    BMC Pediatr; 2022 Sep; 22(1):541. PubMed ID: 36096775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Messaging preferences among Florida caregivers participating in focus groups who had not yet accepted the HPV vaccine for their 11- to 12-year-old child.
    Staras SAS; Bylund CL; Mullis MD; Thompson LA; Hall JM; Hansen MD; Fisher CL
    BMC Public Health; 2022 Dec; 22(1):2413. PubMed ID: 36550434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and predictors of human papillomavirus (HPV) vaccination among young women surviving childhood cancer.
    Klosky JL; Favaro B; Peck KR; Simmons JL; Russell KM; Green DM; Hudson MM
    J Cancer Surviv; 2016 Jun; 10(3):449-56. PubMed ID: 26572902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying Barriers to HPV Vaccination for Patients With Sickle Cell Disease and Childhood Cancer Survivors.
    Rahim MQ; Jacob SA; Coven SL; Miller M; Meagher CG; Lozano G; Zimet G; Ott MA
    J Pediatr Hematol Oncol; 2023 Nov; 45(8):e940-e947. PubMed ID: 37696002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opportunities to Improve HPV Vaccination Among Pediatric, Adolescent, and Young Adult Cancer Survivors by Engaging both Oncology and Primary Care Teams.
    Butsch Kovacic M; Topalian A; Erickson M
    Cancer Prev Res (Phila); 2023 Oct; 16(10):545-547. PubMed ID: 37779459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reasons for refusal of the human papillomavirus vaccine among young cancer survivors.
    Cherven B; Klosky JL; Keith KE; Hudson MM; Bhatia S; Landier W
    Cancer; 2023 Feb; 129(4):614-623. PubMed ID: 36530157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intent and subsequent initiation of human papillomavirus vaccine among young cancer survivors.
    Cherven B; Castellino SM; Chen Y; Wong FL; York JM; Wasilewski-Masker K; Hudson MM; Bhatia S; Klosky JL; Landier W
    Cancer; 2019 Nov; 125(21):3810-3817. PubMed ID: 31291010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors Associated with Intention of Human Papillomavirus (HPV) Vaccine Initiation Among Females With and Without a History of Childhood Cancer.
    Hardin RN; Russell KM; Flynn JS; Gammel HL; Eddinger JR; Schenck LA; Klosky JL
    J Clin Psychol Med Settings; 2020 Dec; 27(4):716-726. PubMed ID: 31587132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human papillomavirus vaccination uptake among childhood cancer survivors in Western New York.
    Garcia M; McGillicuddy C; Rodriguez EM; Attwood K; Schweitzer J; Coley S; Rokitka D; Schlecht NF
    Pediatr Blood Cancer; 2022 Nov; 69(11):e29962. PubMed ID: 36094384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knowledge matters and empowers: HPV vaccine advocacy among HPV-related cancer survivors.
    Shelal Z; Cho D; Urbauer DL; Lu Q; Ma BY; Rohrer AM; Kurian S; Sturgis EM; Ramondetta LM
    Support Care Cancer; 2020 May; 28(5):2407-2413. PubMed ID: 31489512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sexual behaviors and human papillomavirus vaccine non-initiation among young adult cancer survivors.
    Cherven B; Klosky JL; Chen Y; York JM; Heaton K; Childs G; Flynn JS; Connelly JA; Wasilewski-Masker K; Robison LL; Hudson MM; Wong FL; Bhatia S; Landier W
    J Cancer Surviv; 2021 Dec; 15(6):942-950. PubMed ID: 33547560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Provider-Level Barriers to Human Papillomavirus Vaccination in Survivors of Childhood and Young Adult Cancers.
    Kacew AJ; Jacobson S; Sheade J; Patel AA; Hlubocky FJ; Lee NK; Henderson TO; Schneider JA; Strohbehn GW
    J Adolesc Young Adult Oncol; 2022 Jun; 11(3):284-289. PubMed ID: 34403603
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk factors for non-initiation of the human papillomavirus vaccine among adolescent survivors of childhood cancer.
    Klosky JL; Russell KM; Canavera KE; Gammel HL; Hodges JR; Foster RH; Parra GR; Simmons JL; Green DM; Hudson MM
    Cancer Prev Res (Phila); 2013 Oct; 6(10):1101-10. PubMed ID: 23983087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Missed opportunities for concomitant HPV vaccination among childhood cancer survivors.
    Ramsay JM; Kaddas HK; Ou JY; Kepka D; Kirchhoff AC
    Cancer Med; 2022 Feb; 11(4):1181-1191. PubMed ID: 35032104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-Level Factors Associated With Lack of Health Care Provider Recommendation for the Human Papillomavirus Vaccine Among Young Cancer Survivors.
    York JM; Klosky JL; Chen Y; Connelly JA; Wasilewski-Masker K; Giuliano AR; Robison LL; Wong FL; Hudson MM; Bhatia S; Landier W
    J Clin Oncol; 2020 Sep; 38(25):2892-2901. PubMed ID: 32552278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of provider recommendations to restart vaccines after childhood cancer on caregiver intention to vaccinate.
    Warner EL; Vaca Lopez PL; Kepka D; Mann K; Kaddas HK; Fair D; Fluchel M; Knackstedt ED; Pannier ST; Martel L; Kirchhoff AC
    J Cancer Surviv; 2020 Oct; 14(5):757-767. PubMed ID: 32458248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.